With a specialized focus on optimizing pharmaceutical supply chains, Alan has cultivated a track record of implementing transformative reforms and industry best practices. His cross-industry experience has shaped him into a forward-thinking strategist, and his collaborations with leading global companies have enriched his understanding of complex logistics challenges. A founder of the independent GDP Universal Compliance Initiative, he is spearheading a collaborative industry program designed to reform, harmonize and elevate the global distribution standards for life-saving medicines and vaccines.
Archives: Speakers
Melanie Crystal
Experienced Clinical Director with a demonstrated history of working in the medtech and pharmaceuticals industry. Strong program and project management professional skilled in Clinical Research, Drug Development, Medical Devices, and Oncology.
Jonathan Ernst
Jonathan Ernst is Senior Director of In-Home Solutions at PCM Trials, a company that provides home visits by Registered Nurses to support clinical research
Jörg Sturmhoebel Product Manager Wheel Safety
Jörg has a strong background in automotive engineering, working with Audi for many years, within mechanical engineering and project management. He has specialized in brakes and wheels and was transferred to NIRA Dynamics as a resident engineer in the early days of NIRA. Jörg has since worked with engineering, marketing, and business development, where he has focused on the latest development in safety, also from a regulatory perspective.
Thierry Chatenet
Thierry joined Wealth Dynamix as the Switzerland Sales Director in September 2023, to lead the company’s expansion across the region through direct sales. With 25 years of experience in the industry, he is an expert in helping financial services firms navigate and address their digitalisation challenges, ranging from Core Banking systems to e-Banking/Mobile Banking and CRM/CLM space.
Before joining Wealth Dynamix, he held positions at UBS, SAP, Finnova, and Crealogix for several years, as well as previous roles at US tech companies.
Michele Torti
Filippo Menolascina
Filippo Menolascina is a Professor at the University of Edinburgh and the Director of Research at the Bayes Centre, the University’s Innovation Hub for Artificial Intelligence. An Electrical Engineer and Computer Scientist by training (BSc ’06, MSc ’08), Prof Menolascina pioneered the field of “cybergenetics”, the application of intelligent control algorithms to biological systems. Prof. Menolascina, a serial entrepreneur and VC executive, obtained his MBA in 2020 from the University of Edinburgh and currently serves as Managing Director of Noumena Capital, an AI-first Private Equity research firm that develops innovative Machine Learning foundation models to identify and screen prospective investments.
Mike Waters
Mike Waters is the Global VP Biopharma Business Development for Cerba Research. Mike has spent over 25 years in various roles supporting the drug development industry which has seen him work across central & esoteric labs, oncology and virology specialty labs, preclinical development, diagnostics, medical device, and data/technology organizations. Mike Waters holds a Bachelor of Science degree in Medical Technology and is MT(ASCP) certified.
Sandra Kohler
Anna Mayer
Anna has more than 5 years experience in Clinical Investigations with Medical Device and over 8 years with Notified Body Certification of Medical Device Manufacturer.